World Chronic Cough Day 2026: Let’s Talk Cough
Countdown to
15th October
0
days
0
hours
0
minutes
Press release
World Chronic Cough Day 2025 – October 15
“This is a disease, not just a symptom.”
Vienna, Austria — October 15, 2025 — The Global Allergy & Airways Patient Platform (GAAPP) marks World Chronic Cough Day to raise global awareness of chronic cough—a condition often misunderstood, misdiagnosed, and dismissed as “just a cough.”
A Disease in Its Own Right
A chronic cough is one that lasts longer than eight weeks. Once thought to be only a symptom of other illnesses, research now shows that for many people, chronic cough is a distinct disease.
In these patients, the cough reflex becomes hypersensitive, reacting to ordinary stimuli like cold air, talking, laughing, or strong smells. This condition—sometimes called cough hypersensitivity syndrome—can persist even after other underlying problems such as asthma, reflux, idiopathic pulmonary fibrosis or sinus disease are treated.
The Hidden Impact
For millions worldwide, chronic cough is life-altering. Persistent coughing can cause rib pain, fatigue, voice changes, incontinence, and even fainting. The social and emotional toll is equally serious: embarrassment, isolation, anxiety, and disrupted work or relationships.
“Chronic cough is not a nuisance—it’s a disease that steals sleep, confidence, and quality of life,” said Tonya Winders, President & CEO of GAAPP. “World Chronic Cough Day reminds us to listen to patients and take their symptoms seriously.”
Misunderstood and Overlooked
Because chronic cough overlaps with other conditions, patients often endure long journeys before receiving an accurate diagnosis. Many are referred between specialists, undergo repeated tests, or are told the cough is “in their head” despite coughing hundreds of times per day.
Recognition of chronic cough as a stand-alone disease is key to improving care. Patients benefit when health professionals consider refractory or unexplained chronic cough early— particularly when the cough persists despite optimal treatment for other causes.
Progress and Hope
Scientific advances are transforming understanding and management of chronic cough.
- Neuromodulatory therapies that target overactive nerve pathways are showing promise in reducing cough frequency and severity. Other novel treatments targeting other pathways are also in development.
- Speech and behavioral therapies help patients control their cough reflex and restore confidence.
- Patient education and trigger awareness empower individuals to manage daily life more effectively.
Together, these innovations mark a turning point for patients who have long been told there is “nothing more to do.”
A Call to Action
On October 15, GAAPP urges health systems, policymakers, and the public to:
- Recognize chronic cough as a real, disabling disease.
- Improve access to diagnosis and specialized care.
- Support research into causes and treatments.
- Promote empathy and understanding toward those living with the condition.
About GAAPP
The Global Allergy & Airways Patient Platform (GAAPP) is an international network of more than 180 patient organizations working to improve the lives of people affected by allergic, atopic, and respiratory diseases. GAAPP advocates globally for awareness, equitable access to care, and patient-centered research.
For information and resources, visit: